In line with the present study, the NU-AGE study found that MD intervention was associated with positive modulation of gut microbiota which was inversely related to IL-17 levels [24], thus suggesting that MD can modulate the inflammatory response through different mechanisms. Here, IL17A is linked to Menkes disease.